Scholars Central

Short communicationPublished 4 Oct 2013

Role of In-silico modeling in Drug Development for Inhalation Treatment

Authors: Shengqian Wu, Sharareh Salar-Behzadi, Eleonore Fröhlich E

1Research Center, Pharmaceutical Engineering GmbH, Graz, Austria; 2Center for Medical Research, Medical University of Graz, Graz, Austria

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

In-silico modeling is increasingly being used for simulation of adsorption, distribution, metabolization, and excretion to predict the curve of plasma levels and bioavailabilityof oral drug formulations. Computational models for the prediction of other application routes are less common. Preliminary data shows that GastroPlusTM simulation software appears suitable for prediction of drug plasma levels of inhaled drugs in healthy individuals. Since also the influence of physiological variations on lung deposition can be simulated, this software could be a valuable tool in the screening of promising formulations.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Molecular Pharmaceutics & Organic Process Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Molecular Pharmaceutics & Organic Process Research
  • SubjectPharmaceutical Sciences
  • SubjectChemistry
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Shengqian Wu”
  • BylineArticles whose byline prints “Sharareh Salar-Behzadi”
  • BylineArticles whose byline prints “Eleonore Fröhlich E”